Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627684 | 1.00 | TSHR (0.43) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL30143832 | 0.97 | THRB (0.42) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL25864715 | 0.97 | THRB (0.42) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL4482068 | 0.94 | HTT (0.44) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL24412467 | 0.91 | HTT (0.48) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL18902544 | 0.91 | HTT (0.48) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL1702517 | 0.90 | ALDH1A1 (0.50) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL2473861 | 0.90 | ALDH1A1 (0.50) | TSHRALDH1A1HTTTHRBMEN1 | |
| SCHEMBL578972 | 0.90 | TSHR (0.50) | TSHRHTTTHRBMEN1KMT2A | |
| SCHEMBL10057429 | 0.90 | ALDH1A1 (0.50) | TSHRALDH1A1HTTTHRBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113474913-B | Electrochemical device, electronic device, and method for manufacturing electrochemical device | 东莞新能源科技有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-113474913-A | Electrochemical device, electronic device, and method for manufacturing electrochemical device | 东莞新能源科技有限公司 | 2021-10-01 | — | — | CN | disclosed |
| US-9522928-B2 | Mannosylated compounds useful for the prevention and the treatment of infectious diseases | UNIVERSITE DE STRASBOURG (FR) | 2016-12-20 | — | — | US | disclosed |
| US-20160333052-A1 | NOVEL CROSS-LINKED PEPTIDES CONTAINING NON-PEPTIDE CROSS-LINKED STRUCTURE, METHOD FOR SYNTHESIZING CROSS-LINKED PEPTIDES, AND NOVEL ORGANIC COMPOUND USED IN METHOD | JITSUBO CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
| US-20160333050-A1 | NOVEL CROSS-LINKED PEPTIDES CONTAINING NON-PEPTIDE CROSS-LINKED STRUCTURE, METHOD FOR SYNTHESIZING CROSS-LINKED PEPTIDES, AND NOVEL ORGANIC COMPOUND USED IN METHOD | JITSUBO CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
| US-9376467-B2 | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method | JITSUBO CO., LTD. (JP) | 2016-06-28 | — | — | US | disclosed |
| US-9365615-B2 | Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method | JITSUBO CO., LTD. (JP) | 2016-06-14 | — | — | US | disclosed |
| EP-3003041-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | Syngenta Participations AG (CH) | 2016-04-13 | — | — | EP | disclosed |
| EP-2999334-A1 | TANK-MIX FORMULATIONS | Syngenta Participations AG (CH) | 2016-03-30 | — | — | EP | disclosed |
| EP-2999333-A1 | TANK-MIX FORMULATIONS | Syngenta Participations AG (CH) | 2016-03-30 | — | — | EP | disclosed |
| US-20090209726-A1 | ACRYLIC STAR POLYMER | NIPPON SODA CO., LTD. (JP) | 2009-08-20 | — | — | US | disclosed |
| US-20090111961-A1 | Acrylic Acid-Based Polymer and Method of Producing the Same | NIPPON SODA CO., LTD. (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20090111961-A1 | Acrylic Acid-Based Polymer and Method of Producing the Same | NIPPON SODA CO., LTD. (JP) | 2009-04-30 | — | — | US | disclosed |
| US-7494759-B2 | Positive resist compositions and process for the formation of resist patterns with the same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2009-02-24 | — | — | US | disclosed |
| US-7494759-B2 | Positive resist compositions and process for the formation of resist patterns with the same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2009-02-24 | — | — | US | disclosed |
| EP-1892255-A1 | ACRYLIC ACID POLYMER AND METHOD FOR PRODUCING SAME | NIPPON SODA CO., LTD. (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-20070224538-A1 | Positive Resist Compositions and Process for the Formation of Resist Patterns With the Same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070224538-A1 | Positive Resist Compositions and Process for the Formation of Resist Patterns With the Same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1752479-A1 | ACRYLIC STAR POLYMER | NIPPON SODA CO., LTD. (JP) | 2007-02-14 | — | — | EP | disclosed |
| US-5079023-A | During consumption; beverages | HERCULES INCORPORATED (US) | 1992-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160333050-A1 | NOVEL CROSS-LINKED PEPTIDES CONTAINING NON-PEPTIDE CROSS-LINKED STRUCTURE, METHOD FOR SYNTHESIZING CROSS-LINKED PEPTIDES, AND NOVEL ORGANIC COMPOUND USED IN METHOD | NRDC, VIP, NRP1 | TSHR 1379/4885ALDH1A1 4550/4885HTT 2641/4885 |
| US-20160333052-A1 | NOVEL CROSS-LINKED PEPTIDES CONTAINING NON-PEPTIDE CROSS-LINKED STRUCTURE, METHOD FOR SYNTHESIZING CROSS-LINKED PEPTIDES, AND NOVEL ORGANIC COMPOUND USED IN METHOD | NRDC, VIP, NRP1 | TSHR 1379/4885ALDH1A1 4550/4885HTT 2641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.